MYM Nutraceuticals is a fully integrated cannabis company. It is the prime directive of our business plan to be in the medical industry.
Research and development, joint ventures with various universities expand into different countries. Equally important, it is through different global opportunities depending on the country.
Realize the true properties of this plant in different indications – says Rob Gietl, CEO & Director of MYM Nutraceuticals.
An innovative company focus on acquiring Health Canada licenses. It is to produce and sell high-end organic medicinal cannabis addition to topical products.
The shareholder in two production projects in Quebec that when completed will have over 1.5 million of production space.
In addition, the company is a shareholder of 1.2 million of production project in New South Wales, Australia.
Australia is an exciting new market which recently legalized medicinal cannabis.
Ensure a strong presence and growth potential within the industry. MYM is actively looking to acquire complementary businesses.
It also assets in the technology, nutraceuticals and CBD sectors.
Three large-scale production facilities through Joint Ventures are in development.
Moreover, the total amount of greenhouse growing space is expected to exceed 2.7 Million sq. ft.
For more information on MYM Nutraceuticals Inc. (MYM:CSE) please fill out the form below.